VaccImmune Europe ApS: Financial statements 2020
CVR: 39564432
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
VaccImmune Europe ApS (CVR 39564432) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 17,538 compared with DKK -11,931 the year before. Equity in the 2020 report amounted to DKK 1. The solvency ratio was 0%.
- Profit/Loss
- DKK 17,538
- Equity
- DKK 1
- Total Assets
- DKK 10,351
- Employees
- 0
Official annual report
How creditworthy is VaccImmune Europe ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
VaccImmune Europe ApS has published its annual report for 2019. The net result was DKK -11,931.
As of July 15, 2020, Anders Rubinstein is registered as liquidator of VaccImmune Europe ApS.
As of July 15, 2020, Per Horn has stepped down as adm. dir. of VaccImmune Europe ApS.
On July 15, 2020, VaccImmune Europe ApS entered liquidation.
About VaccImmune Europe ApS
VaccImmune Europe ApS was a Danish company of the type Anpartsselskab based in Nivå, founded in 2018. The company has been dissolved on 17 November 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named VaccImmune Europe IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a net result of DKK 17,538 compared with DKK -11,931 the year before. Equity in the 2020 report amounted to DKK 1.
